Decision-making and outcomes of prolonged ICU stays in seriously ill patients
- PMID: 10809459
- DOI: 10.1111/j.1532-5415.2000.tb03144.x
Decision-making and outcomes of prolonged ICU stays in seriously ill patients
Abstract
Background: Despite concern about the high costs and the uncertain benefit of prolonged treatment in the intensive care unit (ICU), there has been little research examining decision-making and outcomes for patients with prolonged ICU stays.
Objectives: To evaluate decision-making and outcomes for seriously ill patients with an ICU stay of at least 14 days.
Design: A prospective cohort study.
Setting: Five teaching hospitals.
Participants: Seriously ill patients enrolled in the Study To Understand Prognoses and Preferences for Risks and Outcomes of Treatments (SUPPORT).
Measurement: Patients, their surrogate decision-makers, and their physicians were interviewed about prognosis, communication, and goals of medical care. Based on age, diagnoses, comorbid illnesses, and acute physiology data, the SUPPORT Prognostic Model provided estimates of 6-month survival on study days 1, 3, 7, and 14. Hospital costs were estimated from hospital billing data.
Results: Of the 9105 patients enrolled in SUPPORT, 1494 (16%) had ICU stays of 14 days or longer. The median length of stay in an ICU was 4 days for the entire SUPPORT cohort and 35 days for patients who were treated in an ICU for 14 days or longer. Median hospital costs were $76,501 for patients who had ICU stays 14 days or longer and $10,916 for patients who did not have long ICU stays. Fifty-five percent of patients with long ICU stays had died by 6 months, and an additional 19% had substantial functional impairment. Among patients with ICU stays of at least 14 days, only 20% had estimates of 6-month survival that fell below 10% at any time during their hospitalization. For patients with long ICU stays, the mean predicted probability of 6-month survival was 0.46 on study Day 3 and 0.47 on study Day 14. Fewer than 40% of patients (or their surrogates) reported that their physicians had talked with them about their prognoses or preferences for life-sustaining treatment. Among the patients who preferred a palliative approach to care, only 29% thought that their care was consistent with that aim. Those who discussed their preferences for care with a physician were 1.9 times more likely to believe that treatment was in accord with their preferences for palliation (95% CI, 1.4-2.5)
Conclusions: Prolonged ICU stays were expensive and were often followed by death or disability. Patients reported low rates of discussions with their physicians about their prognoses and preferences for life-sustaining treatments. Many preferred that care focus on palliation and believed that care was inconsistent with their preferences. Patients were more likely to receive care consistent with their preferences if they had discussed their care preferences with their physicians.
Similar articles
-
A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.JAMA. 1995 Nov 22-29;274(20):1591-8. JAMA. 1995. PMID: 7474243 Clinical Trial.
-
Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.J Am Geriatr Soc. 1997 Apr;45(4):500-7. doi: 10.1111/j.1532-5415.1997.tb05178.x. J Am Geriatr Soc. 1997. PMID: 9100721 Clinical Trial.
-
Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment.Ann Intern Med. 1997 Jul 1;127(1):1-12. doi: 10.7326/0003-4819-127-1-199707010-00001. Ann Intern Med. 1997. PMID: 9214246 Clinical Trial.
-
The effects of patient race on outcomes in seriously ill patients in SUPPORT: an overview of economic impact, medical intervention, and end-of-life decisions. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.J Am Geriatr Soc. 2000 May;48(S1):S194-8. doi: 10.1111/j.1532-5415.2000.tb03132.x. J Am Geriatr Soc. 2000. PMID: 10809475 Review.
-
Association of Surrogate Decision-making Interventions for Critically Ill Adults With Patient, Family, and Resource Use Outcomes: A Systematic Review and Meta-analysis.JAMA Netw Open. 2019 Jul 3;2(7):e197229. doi: 10.1001/jamanetworkopen.2019.7229. JAMA Netw Open. 2019. PMID: 31322688 Free PMC article.
Cited by
-
Survival After Long-Term Residence in an Intensive Care Unit.Fed Pract. 2016 Jun;33(6):18-27. Fed Pract. 2016. PMID: 30766180 Free PMC article.
-
A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUs.Crit Care Med. 2019 Sep;47(9):1184-1193. doi: 10.1097/CCM.0000000000003807. Crit Care Med. 2019. PMID: 31162200 Free PMC article.
-
Long-term outcomes and clinical predictors of hospital mortality in very long stay intensive care unit patients: a cohort study.Crit Care. 2006;10(2):R59. doi: 10.1186/cc4888. Crit Care. 2006. PMID: 16606475 Free PMC article.
-
"It's not just what the doctor tells me:" factors that influence surrogate decision-makers' perceptions of prognosis.Crit Care Med. 2010 May;38(5):1270-5. doi: 10.1097/CCM.0b013e3181d8a217. Crit Care Med. 2010. PMID: 20228686 Free PMC article.
-
Effects of a Personalized Web-Based Decision Aid for Surrogate Decision Makers of Patients With Prolonged Mechanical Ventilation: A Randomized Clinical Trial.Ann Intern Med. 2019 Mar 5;170(5):285-297. doi: 10.7326/M18-2335. Epub 2019 Jan 29. Ann Intern Med. 2019. PMID: 30690645 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical